Rhesus Isoimmunization: Late-onset Hemolytic Disease of the Newborn Without Jaundice
- PMID: 32042531
- PMCID: PMC6996534
- DOI: 10.7759/cureus.6559
Rhesus Isoimmunization: Late-onset Hemolytic Disease of the Newborn Without Jaundice
Abstract
Rhesus (Rh) isoimmunization commonly presents with anemia and jaundice of varying intensity in the early postnatal period and is usually treated with phototherapy and exchange transfusion. Rarely, babies with mild or no symptoms at birth may present later with severe hemolytic anemia. This report describes a newborn infant with no postnatal jaundice who presented during the second week of life with severe anemia. These findings indicate the importance of regular follow-up and close monitoring of Rh-isoimmunized infants during the first two months of life for delayed onset anemia.
Keywords: anemia; blood transfusion; direct coombs test; hdn; jaundice; newborn; phototherapy; rh isoimmunization.
Copyright © 2020, Haider et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Rh-immunoglobulin: Rh prophylaxis. Bowman J. Best Pract Res Clin Haematol. 2006;19:27–34. - PubMed
-
- Management of the Rh-sensitized mother. Gollin YG, Copel JA. Clin Perinatol. 1995;22:545–559. - PubMed
-
- RhD haemolytic disease of the fetus and the newborn. Urbaniak SJ, Greiss MA. Blood Rev. 2000;14:44–61. - PubMed
-
- Rhesus isoimmunization: increased hemolysis during early infancy. Hayde M, Widness JA, Pollak A, Kohlhauser-Vollmuth C, Vreman HJ, Stevenson DK. Pediatr Res. 1997;41:716–721. - PubMed
Publication types
LinkOut - more resources
Full Text Sources